The microRNA miR-182, belonging to the miR-183 family, is one of the most frequently studied cancer-related oncogenic miRNAs that is dysregulated in various cancer tissues, and it plays a crucial role in tumorigenesis and tumor progression. Studies 
reported that metastasis is one of the most devastating aspects of lung cancer, and the major cause of death from lung cancer. 3 However, the underlying molecular mechanism of metastasis remains unknown, and there is a lack of available therapies that are effective against metastasis.
It is generally agreed that the process of tumor metastasis is a multi-step process that is precisely regulated by a variety of factors.
Tumor metastasis involves a series of changes in tumor metastasisrelated genes. 4 Increasing evidence indicates that the epithelialmesenchymal transition (EMT) plays a critical role in cancer metastasis.
Epithelial-mesenchymal transition is a process whereby differentiated epithelial cells lose their cell polarity and cell-cell adhesion and a migratory, mesenchymal phenotype. 5 The epithelial cells acquire a fibroblast-like, mesenchymal appearance, which is accompanied by reducing of epithelial markers such as E-cadherin, ZO-1, and cytokeratin expression, and up-regulation of mesenchymal markers such as vimentin and N-cadherin. However, the exact molecular mechanism of EMT is not fully understood and the molecular pathways underlying each step are still obscure. Generally, the activation of a wide variety of ligands and their receptors can increase the expression of EMT-inducing transcription factors, such as Snail, Snai2 (also known as Slug), ZEB1, ZEB2, and Twist. 6 Among them, hepatocyte growth factor (HGF; also known as the scattering factor, SF) activates the Met signaling pathway by the phosphorylation cascade, regulates EMT, and thereby increases the invasive and metastatic potential of the cells. 7 Therefore, the HGF/Met signaling pathway as a therapeutic target to inhibit angiogenesis and some cancers, and many other targeted drugs are in development. 8 In addition to alterations in protein-encoding genes, an increasing number of studies have pointed to an important role for microRNAs (miRNAs) in the initiation and progression of most cancers, including tumor metastasis. 9 The miRNAs are 20-25 nt non-coding short single-stranded RNA molecules that serve as master regulators of gene expression by binding to sites in the 3′-untranslated region (UTR) of target mRNAs and negatively regulating gene expression. 10 For example, miR-10b was found to promote in vitro and in vivo migration, invasion, and metastasis in breast cancer cells by targeting HOXD10 and regulating the prometastatic transcription factor TWIST1. 11 It was reported that miR-335, miR-126, and miR-206 were consistently downregulated in the metastatic foci. Additionally, they also reported that low miR-335 or miR-126 expression was associated with poor metastasis-free survival by directly targeting SoX4. 12 miR-182 is located in the human chromosome 7q31-34 adjacent to the human Met, BRAF oncogene. 13 Segura et al reported that aberrant miR-182 expression promotes melanoma metastasis by targeting FOXO3 and the microphthalmia-associated transcription factor. 14 Barshack et al reported that miR-182 expression differentiates between primary lung tumors and metastases to the lung, and considered miR-182 as a potential clinical biomarker for surgical pathologists faced with discerning the tumor type of an inscrutable lung neoplasm. 15 However, the mechanism of miR-182 in lung cancer metastasis is far more understood. 16 The paired highly and lowly metastatic human lung adenocarcinoma cell lines 95D and 95C, respectively, were from SGST (Shanghai, China). All the cell lines were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS;
Life Technologies, Carlsbad, CA), penicillin (100 U/mL), and streptomycin (100 U/mL) in a humidified incubator set at 37°C with an atmosphere of 5% CO 2 . Table 1 contains basic information on the research cohort.
| Tissue samples

| RNA and miRNA extraction
Total cellular RNA or tissue RNA was isolated using the Trizol reagent (Invitrogen, CA) according to the manufacturer's instructions.
The miRNAs were isolated using the miRNeasy Mini Kit (Qiagen, Shanghai, China) according to the manufacturer's instructions. RNA was quantified using a UV spectrophotometer (Beckman Coulter, CA).
| Reverse transcription and real-time polymerase chain reaction (qRT-PCR)
For the detection of miR-182, 50 ng of total RNA were reverse transcribed into complementary DNA (cDNA), and cDNA was amplified using a miRNA-specific TaqMan miRNA assay kit (Applied Biosystems, Foster City, CA). The relative transcript levels of Met, E-cadherin, and Snail were detected using SYBR ® Green PCR Master Mix (Applied Biosystems). Real-time PCR was carried out using an ABI 7900HT Fast Real-time PCR system (Applied Biosystems) according to the manufacturer's recommended conditions. Experiments were performed in triplicate. The U6 or GAPDH were used as normalized controls and the relative levels of miR-182 were calculated using the 2 −ΔCT methods, while the fold change in other genes expression was calculated as 2 −ΔΔCt .
| Cell migration and invasion assays
Cell migration or invasion assays were performed using the 24-well For wound healing assay, A549 or H1299 cells were seeded at 90% confluence into six-well plates after transfection. Confluent monolayers were scratched using a sterile 200 µL pipette tip and washed with PBS and then replaced with normal cell culture medium.
Cells were photographed at various time points with an inverted microscope (Nikon TE2000). The distance of each scratch closure was measured using Image J software and then calculated by the formula:
(0 h wound width − 24 h wound width)/0 h wound width × 100%.
| Luciferase assay
The 3′UTR of the human Met gene was amplified using PCR and cloned into a pGL3 vector to generate pLuc-MET-3′UTR (wt). The pLuc-MET- temperature. Cells were incubated with probed with anti-E-cadherin antibody (1:500, BD Biosciences) or rabbit-anti-FN, rabbit anti-Snail 
| Statistical analysis
Statistical analysis was performed using the software package SPSS version 21.0. Students' t-test was used for differences between two groups. Mann-Whitney U and Kruskal-Wallis tests were applied to the examination of relationship between miRNA-182 or Met expression and clinicopathological parameters. The relationship of miRNAs with survival was studied using Kaplan-Meier method, while significant differences between curves were evaluated using log-rank test. All
P-values obtained in this study were two-tailed, and the statistical significance level was set at P < 0.05.
3 | RESULTS 3.1 | MiR-182 is frequently downregulated in metastatic non-small cell lung cancer cells and tumor tissues
To determine whether miR-182 expression correlated with clinical characteristics in patients, first we measured its expression levels in primary tumor samples from 58 cases of NSCLC patients using realtime PCR, and the results were compared with RNU6B as the internal reference gene. As shown in Table 2 , expression of miR-182 correlated with LN metastasis in NSCLC (P = 0.046, Mann-Whitney U-test. Figure 1A , To determine the survival differences according to the miR-182 expression levels, Kaplan-Meier plots were constructed. As shown in Figure 1D , increased survival was associated with high expression levels of miR-182 (51 vs 37 months, P = 0.076). However, the lack of a statistically significant result may be attributed to the small sample size. Figure 2B ). Also, the wound-healing assay showed the same tendency (P < 0.05, Figure 2C ). These results further indicated that miR-182 suppresses the migration and invasion capacity of A549, H1299, and 95C cells in vitro.
3 
| Met is a direct and functional target of miR-182
To further study the mechanism by which miR-182 regulate the EMT and metastasis of NSCLC cells. We used miRNA target prediction tools, such as the TargetScan Collectively, these findings indicated that miR-182 might negatively regulate the expression of Met by directly binding to its 3′-UTRs.
To determine whether Met is involved in regulating cell invasion and Figure 5B). These results suggested an inverse correlation between miR-182 expression and Met expression, which further supported the involvement of miR-182 in lung cancer metastasis in humans.
We also evaluate the association between miR-182 level and the prognosis of NSCLC patients by Kaplan-Meier survival analysis. As shown in Figure 5C , it revealed that patients with higher Met expression tended to have a poorer prognosis (34 vs 51 months, P = 0.056), which was opposite from the result obtained for miR-182.
However, the result was not statistically significant, and this may be attributed to the small sample size. These results also suggested an inverse correlation between miR-182 and Met expression. However, we still did not find a significant correlationship between the expression of miR-182 and Met expression in this small size samples (P > 0.05).
| MiR-182 represses HGF-induced migration, invasion, and EMT of lung cancer cells by target met
Met is known to play an important role in a plethora of biological and biochemical effects in cancer cells together with its natural ligand HGF/SF. 19 Based on the findings above, we surmised that miR-182
functions as a repressor of HGF/Met signaling, and thus represses HGF-induced lung cancer migration, invasion and the EMT process, which may otherwise trigger the EMT by downregulating E-cadherin.
Loss of E-cadherin is considered to be the most important molecular marker of EMT. 20 As expected, HGF treatment increased migration and invasion as well-reduced E-cadherin levels in lung cancer cell lines 
